Progesterone

Arefam, Cyclogest, Novitera, Progedex · ATC code G03DA04

Also known as: Progesteron, Prometrium · Brand names: Arefam, Cyclogest, Novitera, Progedex, Utrogestan, Crinone, Cyclogest®, Estima, Famenita, Lutinus, Progestan, Progestogel, Prolutex, Utrogest Luteal, Gestinax …

Key facts
Active substance
Progesterone
ATC code
G03DA04
Authorisation
authorised nationally; no central EU authorisation
Information as of
2026-10-27

Key facts

Progesterone is a natural progestogen. Per the US label, the capsules are used to prevent endometrial hyperplasia in postmenopausal women on estrogen and to treat secondary amenorrhea.

What it is used for

  • Prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women receiving conjugated estrogens
  • Secondary amenorrhea

Dosing

  • Endometrial hyperplasia prevention: 200 mg once daily at bedtime for 12 days sequentially per 28-day cycle, with daily conjugated estrogens
  • Secondary amenorrhea: 400 mg once daily at bedtime for 10 days
  • Women with difficulty swallowing should take the capsules with a glass of water while standing
  • May cause drowsiness; taken at bedtime

Contraindications

  • Hypersensitivity to ingredients; capsules contain peanut oil (contraindicated in peanut allergy)
  • Abnormal genital bleeding of unknown etiology
  • Known, suspected or history of breast cancer
  • Active or history of deep vein thrombosis, pulmonary embolism or arterial thromboembolic disease (e.g. stroke, myocardial infarction)
  • Known liver dysfunction or disease

Important warnings

  • Discontinue immediately if PE, DVT, stroke or MI occurs; if feasible stop 4 to 6 weeks before surgery with increased thromboembolism risk
  • The WHI trial reported increased risks of PE, DVT, stroke and MI with estrogen plus progestin
  • More abnormal mammograms with estrogen plus progestin; discontinue if a hormone-sensitive malignancy is diagnosed
  • Drowsiness and dizziness: caution when driving or operating machinery

Side effects

  • In a trial (with conjugated estrogens), common: headache (31%), breast tenderness (27%), joint pain (20%), depression (19%), dizziness (15%)
  • Others: abdominal bloating, hot flashes, urinary problems, vaginal discharge, nausea/vomiting

Pregnancy and breastfeeding

  • Should not be used during pregnancy
  • Progestins have been detected in breast milk; use caution in nursing women

Summary of the official product information, written with AI (Claude, Anthropic) on 2026-10-28. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.

Full official text →

Common questions – ask Medelix

For patients

Patient information (US)

Patient information (US) →

Authorisation and brand names by country

Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.

Austria

  • ArefamExeltis Germany Gmbh · 1 register entry
  • CyclogestGedeon Richter Plc. · 1 register entry
  • NoviteraExeltis Germany Gmbh · 1 register entry
  • ProgedexIbsa Farmaceutici Italia · 3 register entries
  • UtrogestanBesins Healthcare S.A., Besins Healthcare Germany Gmbh · 3 register entries

Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28

Germany

  • CrinoneMerck Healthcare Germany Gmbh · 1 register entry
  • CyclogestGedeon Richter Plc. · 1 register entry
  • Cyclogest®Gedeon Richter Plc. · 1 register entry
  • EstimaEffik · 1 register entry
  • FamenitaExeltis Germany Gmbh · 1 register entry
  • LutinusFerring Gmbh · 1 register entry
  • ProgestanBesins Healthcare Germany Gmbh · 1 register entry
  • ProgestogelBesins Healthcare Germany Gmbh · 1 register entry
  • ProlutexIbsa Farmaceutici Italia · 2 register entries
  • Utrogest LutealBesins Healthcare Germany Gmbh · 1 register entry

Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28

Turkey

  • CrinoneMERCK İLAÇ ECZA VE KİMYA TİC. A.Ş., SERONO İLAÇ PAZ. VE TİC. A.Ş. · 2 register entries
  • CyclogestASSOS İLAÇ KİMYA GIDA ÜRÜNLERİ ÜRETİM VE TİC. A.Ş. · 2 register entries
  • GestinaxDEVA HOLDİNG A.Ş. · 2 register entries
  • PregetoxDEVA HOLDİNG A.Ş. · 2 register entries
  • ProgestanKOÇAK FARMA İLAÇ VE KİMYA SAN. A.Ş. · 8 register entries
  • ProgynexFARMAKO ECZACILIK A.Ş., KOÇAK FARMA İLAÇ VE KİMYA SAN. A.Ş. · 6 register entries
  • ProlutexIBSA İLAÇ SAN. VE TİC. LTD. ŞTİ. · 1 register entry
  • PromesterVEM İLAÇ SAN. VE TİC. A.Ş. · 2 register entries

Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16

USA

  • CrinoneAllergan, Inc. · 1 register entry
  • EndometrinFerring Pharmaceuticals Inc. · 1 register entry
  • PrometriumAcertis Pharmaceuticals, LLC · 1 register entry

Source: U.S. FDA – Drug labels (openFDA/DailyMed), as of 2026-10-28

Brand names in 27 more European countries
Belgium
Amelgen, Gepretix, Inprosub, Progebel, Progestogel, Utrogestan
Bulgaria
Prolutex, Кринон, Лутинус, Прогестогел, Пролутекс, Утрогестан, Циклогест
Croatia
Crinone, Cyclogest, Utrogestan
Cyprus
Cyclogest, Prolutex, Utrogestan, Vasclor
Czechia
Agolutin, Amelgen, Gynprodyl, Progesteron Besins, Prolutex, Utrogestan
Denmark
Crinone, Cyclogest, Lutinus, Prolutex
Estonia
Amelgen, Crinone, Gepretix, Lubion, Utrogestan
Finland
Crinone, Cyclogest, Gepretix, Lugesteron, Lutinus, Prolutex
France
Amelgen, Crinone, Estima, Phasella, Progestan, Progesterone Biogaran, Progesterone Viatris, Progestogel, Progiron, Utrogestan
Greece
Crinone, Cyclogest, Lutinus, Mastopon-Treat, Prolutex, Promenorea, Vasclor
Hungary
Crinone, Cyclogest, Lutinus, Progesterone Exeltis, Prolutex, Utrogestan
Iceland
Crinone, Cyclogest, Lutinus, Progestan, Progesterone Alvogen
Ireland
Crinone, Lubion, Lutinus, Progesterone
Italy
Amelgen, Crinone, Esolut, Pleyris, Prometrium, Prontogest, Utrogestan
Latvia
Amelgen, Crinone, Gepretix, Lubion, Lutavia
Lithuania
Crinone, Gepretix, Lubion, Lutavia, Progesterone Besins
Luxembourg
Amelgen, Inprosub, Progebel, Progestogel, Utrogestan
Malta
Cyclogest, Seidigestan, Utrogestan
Netherlands
Crinone, Cyclogest, Lutinus, Prolutex, Utrogestan
Norway
Crinone, Cyclogest, Gepretix, Lutinus, Prolutex
Poland
Crinone, Cyclogest, Famenita, Lustork, Luteina, Lutezin, Lutinus, Progesteron Adamed, Prolutex, Utrogestan
Portugal
Cyclogest, Folac, Gepretix, Gosegyne, Prolutex, Utrogestan
Romania
Arefam, Crinone, Cyclovita, Lutinus, Mastoprofen, Prolutex, Utrogestan
Slovakia
Agolutin, Amelgen, Progestanelle, Prolutex, Utrogestan
Slovenia
Amelgen, Crinone, Utrogestan
Spain
Cyclogest, Darstin, Fergesten, Gepretix, Progeffik, Prolutex, Seidigestan, Utrogestan
Sweden
Crinone, Cyclogest, Gepretix, Lutinus, Prolutex, Utrogestan

EMA – Article 57 product data (EU/EEA), 2026-10-28

Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.

Another question about this substance?

Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.

Sources

  1. U.S. Food and Drug Administration. Prometrium (Acertis Pharmaceuticals, LLC) – Prescribing Information, 2026-07-23. DailyMed (NLM), 2026-10-27. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1cf237ff-c4f8-4faa-a7aa-77599c856889
  2. EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
  3. EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
  4. TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
  5. U.S. FDA – Drug labels (openFDA/DailyMed), 2026-10-28. https://dailymed.nlm.nih.gov/dailymed/

Editorial: Medelix editorial team · last updated 2026-10-27 · How these pages are made · Report an error

Source: U.S. Food and Drug Administration (FDA), prescribing information, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.